PS
PsyBio Therapeutics Corp
PSYBF · OTC
$0.00 +0.00% (+$0.00)
Market Cap $1.27K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
-
N/A P/FFO N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
57 /100
Average ROA 1,251.65%
Asset turnover 0.00x
ROIC 341.54%
Debt
50 /100
Moderate Int. coverage -221.93x
Net debt/EBITDA -0.03x
Current ratio 0.13x
Stability
47 /100
Moderate Profitable years 0
Beta 0.49x
EPS volatility N/A
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PSYBF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Evan Levine
Employees
118
Headquarters
Denver